In the most common tauopathy, Alzheimer’s disease, and in some forms of frontotemporal dementia, the sites of neurodegeneration correlate with deposits of an aberrant hyperphosphorylated tau. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.